Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Tenaya Therapeutics Inc TNYA

Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:TNYA)

No current opinion is available.

Bullboard Posts (NDAQ:TNYA)

(TNYA) Investment Report

BREAKING NEWS: $TNYA (TNYA) Investment Report2024-03-08 04:44:00 ET Stock Traders Daily has produced this trading report using a...
whytestocks - March 8, 2024

Tenaya Therapeutics to Participate in Upcoming March Investo

NEWS: $TNYA Tenaya Therapeutics to Participate in Upcoming March Investor ConferencesSOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE...
whytestocks - February 27, 2024

Tenaya Therapeutics Announces Pricing of Underwritten Offeri

NEWS: $TNYA Tenaya Therapeutics Announces Pricing of Underwritten Offering | BenzingaSOUTH SAN FRANCISCO, Calif., Feb. 08, 2024 (GLOBE...
whytestocks - February 8, 2024